A series of metabolic changes within the immature rat uterus begins minutes after the administration of microgram quantities of estradiol (E 2 ). One of the earliest effects that has been measured is an increase in the rate at which the uterus takes up glucose. To characterize the effect of E 2 on glucose transport stimulation, whole protein preparations were examined for the presence of mammalian glucose transport proteins Glut1 through Glut5. E 2 -stimulated changes in the steady state levels of messenger RNA (mRNA) and protein were measured for Glut1 and Glut4 by quantitative competitive RT-PCR and Western blots. Both Glut1 mRNA and protein increased approximately 3-to 4-fold within 4 -8 h. This increase in Glut1 mRNA and protein agrees with the maximal stimulation of the glucose transport rate that was observed. No translocation of either Glut1 or Glut4 was observed 2 h after E 2 injection, indicating that translocation is not the mechanism responsible for the initial E 2 -stimulated increase in glucose transport observed in immature rat uterus. These data support the conclusion that the prolonged increase in glucose transport rate is due to either the transcriptional activation of Glut1 and/or the increased Glut1 mRNA half-life. (Endocrinology 140: [3602][3603][3604][3605][3606][3607][3608] 1999) T HE RATE OF glucose transport into cells is known to be regulated by a wide assortment of both peptide and steroid hormones, including but not limited to serum (1), epidermal growth factor, fibroblast growth factor, plateletderived growth factor (2-5), insulin (6), and estrogen (7). Early studies characterized the glucose transport response to serum as being biphasic (1), with an early phase that is not sensitive to cycloheximide and a later phase that is sensitive. This type of regulation has been further characterized for specific growth factors such as insulin-like growth factor I. The mechanism of glucose transporter stimulation by insulin-like growth factor I involves two responses. The first is an early cycloheximide-insensitive response involving the translocation of glucose transporters Glut1 and Glut4 to the plasma membrane, and the second is a cycloheximidesensitive response that involves the synthesis of new transporter proteins (8).
T HE RATE OF glucose transport into cells is known to be
regulated by a wide assortment of both peptide and steroid hormones, including but not limited to serum (1) , epidermal growth factor, fibroblast growth factor, plateletderived growth factor (2-5), insulin (6) , and estrogen (7) . Early studies characterized the glucose transport response to serum as being biphasic (1) , with an early phase that is not sensitive to cycloheximide and a later phase that is sensitive. This type of regulation has been further characterized for specific growth factors such as insulin-like growth factor I. The mechanism of glucose transporter stimulation by insulin-like growth factor I involves two responses. The first is an early cycloheximide-insensitive response involving the translocation of glucose transporters Glut1 and Glut4 to the plasma membrane, and the second is a cycloheximidesensitive response that involves the synthesis of new transporter proteins (8) .
Recent experiments have partially characterized the early (1-2 h) estradiol (E 2 ) effects on glucose transport, and the results indicate that E 2 is an important regulator of Glut1. A sc injection of 100 g/kg E 2 2 h before middle cerebral artery occlusion has been shown to reduce subsequent focal ischemic damage in rats (9) . E 2 -treated rats also show higher Glut1 protein levels in the penumbral region of the ischemic lesions than control animals. These data represent more than a correlation, because rats transfected with Glut1 also show increased neuronal survival after middle cerebral arterial occlusion (10) . Treatment with E 2 also reduces the glucose transport inhibition caused by chemical insults related to Alzheimer's disease; a 1-h E 2 pretreatment of synaptosomes prepared from rat cerebral hemispheres results in a reduced level of glucose transport impairment caused by FeSO 4 or amyloid B peptide (11) . It is important to note that the prepared synaptosomes lack nuclei, suggesting that E 2 may effect glucose transport without affecting glucose transporter transcription.
One of the most carefully studied estrogen-responsive model systems is the rat uterus (12) . E 2 treatment causes an entire series of growth-related responses, including an increase in the uptake rate of amino acids, nucleic acids, and glucose. The increase in the glucose transport rate after a single injection of microgram quantities of E 2 was shown to be inhibited by the protein synthesis inhibitor cycloheximide (7) . The degree of stimulation was similar to that of peptide hormones epidermal growth factor and fibroblast growth factor, and the kinetics [an increased maximum velocity (V max ) and constant K m ] suggest that E 2 regulation of glucose transport, like the second response observed for peptide hormones, involves increased levels of glucose transporter protein synthesis. These data are consistent with a model in which stimulation of glucose transport by E 2 in the immature rat uterus is the result of increased glucose transporter transcription and/or increased messenger RNA (mRNA) halflife, resulting in the associated accumulation of new glucose transporter protein.
Materials and Methods

Sample preparation
Nineteen-day-old female Sprague Dawley rats (Harlan Sprague Dawley, Inc., Madison, WI) were injected ip with 250 l ethanolic saline (control) or with 250 l ethanolic saline plus 1 g 17␤-E 2 (Sigma Chemical Co., St. Louis, MO). Injections were performed at various intervals before death. Death by decapitation was carried out simultaneously for all animals. Uteri were removed, stripped of fat, and immediately frozen on dry ice. Total RNA and total protein were isolated using Tri-Reagent (Molecular Research Center, Inc., Cincinnati, OH), a system based on guanidium thiocyanate/phenol-chloroform extraction. Protein samples were recovered through dialysis against 0.1% SDS (3500 mol wt cut-off; Spectra/Por membrane, Spectrum Laboratories, Laguna Hills, CA) at room temperature with three changes of 0.1% SDS. Bradford assays were performed to quantify protein levels, and samples were concentrated by trichloroacetic acid precipitation before electrophoresis. RNA concentration and purity were determined spectrophotometrically.
RT-quantitative competitive-PCR (RT-qc-PCR) control synthesis
Primers for RT-qc-PCR were chosen that amplified both 124-and 137-bp fragments of rat Glut1 and Glut4, respectively. Construction of the PCR control fragment was performed by a modification of the method of Siebert et al. (13) . Briefly, oligonucleotides complementary to primers used to amplify Glut1 and Glut4 were synthesized with 3Ј-overhangs. Each overhang contains a half-site of a different restriction enzyme. These complementary oligonucleotides were annealed with the PCR primers and were then ligated onto a DNA restriction enzyme fragment possessing ends complementary to those restriction half-sites encoded by oligonucleotide 3Ј-overhangs. Products of the ligation reaction were amplified using PCR; the resulting fragment was gel purified and inserted into pGEM-3Zfϩ (Promega Corp., Madison, WI). Transcripts of the inserts were made, and the reaction mixture was subsequently treated with deoxyribonuclease I (Promega Corp.) until no amplification could be observed without first reverse transcribing the samples. Primers to Glut1 and Glut4 contained a single degenerate base, so the control RNA was isolated with both forms of primer, and equal amounts of both were included in the RT-qc-PCR reaction.
RT-qc-PCR
Large preparations of RT reaction mixture were made, aliquoted into tubes containing serial dilutions of control RNA, and incubated at 42 C for 1 h. Primers chosen for the PCR reaction were from Sivits et al. (14) . RT reactions were amplified by PCR for 27 cycles (95, 55, and 72 C) with Taq DNA polymerase (Promega Corp.). Mineral oil overlay was removed, and an aliquot was loaded onto a 3.5% high resolution agarose gel (Amresco, Solon, OH; and FMC BioProducts, Rockland, ME) containing 0.5 g/ml of ethidium bromide, electrophoresed at approximately 9 V/cm, visualized by UV light, and exposed to Polaroid film (Polaroid Corp., Cambridge, MA). Quantification was performed with NIH Image 1.6 software.
Western blots
Equal amounts of proteins were separated by SDS-PAGE and transferred to nitrocellulose membrane. Antibodies to glucose transporters were provided by the following: antibodies against Glut1, Glut2, Glut3, and Glut4 were from Charles River Pharmservices (Southbridge, MA), and antibody against Glut5 was a gift from Charles F. Burant (University of Chicago, Chicago, IL). All Glut antibodies were made either against rat protein (Glut1, -2, -4, and -5) or against mouse protein (Glut3), and this antibody was tested and found to strongly cross-react with rat Glut3 protein. Antibody against Na ϩ ,K ϩ -adenosine triphosphatase (Na ϩ ,K ϩ -ATPase) was obtained from Upstate Biotechnology, Inc. (Lake Placid, NY). Nitrocellulose membranes were blocked with 50% horse serum in PBS containing 0.5% (vol/vol) Tween-20, and all antibody incubations were performed in 10% horse serum in PBS containing 0.5% (vol/vol) Tween-20. Antibodies were detected by chemiluminescence (NEN-DuPont, Boston, MA).
2-Deoxyglucose uptake assay
Rats were treated at various intervals with a single 1-g ip injection of E 2 and were killed together (except for the 15 min point, which was performed separately after the 8 h point). Two rats were pooled at each time point. Rats were killed, and their uteri were removed and placed into HBSS (Sigma Chemical Co.) with 0.1 mm [
Subcellular fractionation
Nineteen-day-old female Sprague Dawley rats (Harlan Sprague Dawley, Inc.) were injected with ethanolic saline or E 2 as previously described, or they were injected sc with 200 l 150 mm sodium pyrophosphate plus 10 U human recombinant insulin Novolin R (Novo Nordisk, Bagsvaerd, Denmark). Cell membrane preparations were performed by a modification of the method described by Hirshman et al. (15) . Briefly, samples were homogenized with a Tissumizer (model SDT-100N, Tekmar Co., Cincinnati, OH) at 20,000 rpm for two to three bursts of 5 sec each in a buffer containing 100 mm Tris (pH 7.5), 20 mm EDTA (pH 8.0), and 255 mm sucrose (pH 7.6). The homogenate was then centrifuged at 1,000 ϫ g for 5 min, and the resulting supernatant was centrifuged again at 48,000 ϫ g for 20 min. The pellet from this centrifugation was used for the preparation of the membrane fraction, which was enriched in the membrane marker Na ϩ ,K ϩ -ATPase, and the supernatant was used for the preparation of the microsomal fraction.
The membrane fraction was prepared by resuspending the pellet in 20 mm HEPES and 250 mm sucrose, pH 7.4 (buffer A). An equal volume of a solution containing 600 mm KCl and 50 mm sodium pyrophosphate was added, and the mixture was vortexed, incubated for 30 min on ice, and then centrifuged for 1 h at 227,000 ϫ g. The resulting pellet was resuspended in buffer A and centrifuged for 1 h at 135,000 ϫ g over a 36% sucrose cushion in buffer A. The resulting interface and all of the buffer above it were collected, diluted in an equal amount of buffer A, and centrifuged for 1 h at 227,000 ϫ g. The resulting pellet was used as the membrane fraction.
The microsomal fraction was prepared from the supernatant of the initial 48,000 ϫ g centrifugation. The supernatant was centrifuged for 1 h at 227,000 ϫ g. The resulting pellet was used as the microsome fraction. Preparations were kept on ice during the protocol, and all centrifugations were performed at 4 C. Western blots were performed on the protein pellet from the sucrose cushion and initial homogenate for both Na ϩ ,K ϩ -ATPase and glucose transporters to confirm that membrane markers were being selectively isolated and concentrated in the plasma membrane, and that no significant population of either glucose transporter was contained in any fraction except the plasma membrane and microsome fractions.
Results
Characterizing the effect of E 2 with respect to time and intensity
Glucose uptake was measured at various intervals over a period of 8 h (Fig. 1) . The rate of glucose uptake into uterine cells is determined by measuring how much [
3 H]2dog is converted to [ 3 H]2dog-6-P by hexokinase, the first step in glycolysis. Increased levels of [ 3 H]2dog-6-P were detected when rats were killed 30 min to 1 h after E 2 injection, and this increased level of [ 3 H]2dog-6-P reached a plateau when the time between E 2 injection and death was between 4 -8 h. Although some of the experimental conditions differed from earlier studies (7, 16) (i.e. the age of rats, the amount of E 2 injected, the uterine incubation medium and temperature, etc.), these observations are in general agreement with these previous data in that a single injection of microgram quantities of E 2 causes a stimulation of glucose transport that is detectable within 30 min and that peaks within several hours.
Immature rat uterus expresses glucose transporter isoforms Glut1 and Glut4
As a first step to characterizing glucose transporter expression and response to E 2 in immature rat uterus, uterine tissue was tested for the presence or absence of glucose transporters Glut1 through Glut5. At least one tissue known to express each of the glucose transporters was also run as a positive control and as a reference with respect to mol wt and relative levels of expression. Western blots were performed for each of the transporters using equal amounts of protein from brain, kidney, jejunum, skeletal muscle, and uterus (Fig. 2) . Of the tissues used as controls for glucose transporter expression, Glut1 expression was highest in brain; however, Glut1 was found to be expressed in most tissues. Glut2 was found in kidney and jejunum, and Glut3 was found predominantly in brain, although it was also detected in skeletal muscle. Glut4 expression was highest in skeletal muscle, and Glut5 expression was highest in kidney, although it also was expressed in jejunum and brain (17, 18) . Analysis of whole protein preparations in these tissues revealed the appropriate expression patterns in the various glucose transporter target tissues.
With respect to uterine expression of glucose transporters Glut1 through Glut5, Glut3 and Glut5 were not detected in Western blots of whole protein. In addition, no band corresponding to the mol wt of Glut2 was detected in uterus. Antibody against Glut2 did specifically detect the protein in other tissues, but with noticeable background fluorescence. Glut2 protein has been reported at more than one mol wt, depending on the tissue in which it is expressed (19); therefore, two controls were performed to confirm that immature rat uterus did not express Glut2. First, a second Western blot was performed to demonstrate that no protein appears in the uterine sample that corresponds to either the mol wt of Glut2 in kidney or jejunum (data not shown). Second, RT-PCR was performed on uterine, kidney, and liver RNA to amplify a fragment of Glut2 mRNA and determine whether any Glut2 mRNA could be observed in the uterine sample (Fig. 3) . Glut2 mRNA was not detected in uterine complementary DNA, but Glut2 was detected in both liver and kidney complementary DNA as expected. These data support the conclusion that Glut2 is not expressed in the immature rat uterus.
Therefore, Glut1 and Glut4 proteins were the only glucose transporters detected in the Western blots of whole protein samples from immature rat uterus. The level of Glut1 protein in the uterus was higher than the level in skeletal muscle, which expressed moderate levels of Glut1. The level of Glut4 expressed in uterus was relatively low, far below the level observed in skeletal muscle and approximately equal to the level observed in kidney. This indicates that Glut1 may be the primary glucose transporter in the immature rat uterus; however, no direct comparisons were made between Glut1 and Glut4 expression levels in rat uterus, so no conclusions can be drawn with respect to relative expression levels.
Effect of E 2 on Glut1 and Glut4 protein and mRNA levels with respect to time
Having demonstrated that Glut1 and Glut4 were the glucose transporter proteins detected in immature rat uterine tissue, uterine RNA and protein samples were collected over a time course of E 2 treatment to determine whether either Glut1 or Glut4 expression levels change with E 2 treatment. Western blots measuring both Glut1 and Glut4 protein levels in immature rat uteri were performed for a series of E 2 treatments ranging from 1-12 h between injection and death (Fig. 4) . Glut1 protein levels increased between the 2 and 4 h E 2 treatments, whereas Glut4 protein levels did not change during the time course. These results suggest that increased levels of Glut1 protein contribute to the observed increase in glucose uptake after E 2 injection. E 2 stimulation of glucose uptake is sensitive to cycloheximide (7), indicating that new protein synthesis is a requisite component. To determine whether increased protein levels of Glut1 might be a result of increased Glut1 mRNA, steady state levels of Glut1 and Glut4 mRNA were measured at times after E 2 treatment. RT-qc-PCR was used to detect changes in Glut1 and Glut4 mRNA levels, because neither Northern blots nor ribonuclease protection assays were sufficiently sensitive due to a low abundance of signal. RT-qc-PCR was performed on Glut1 and Glut4 mRNA simultaneously as previously described (see Materials and Methods). Total RNA was isolated from rat uteri after E 2 treatments for 1-10 h (Fig. 5) . Glut4 steady state mRNA levels did not change in response to E 2 over the time course of the experiment. This result is in agreement with the constant levels of Glut4 protein that were measured after the same E 2 time course. Glut1 mRNA levels increased approximately 4-fold relative to control values within 4 -6 h after E 2 treatment, coinciding with the increase in Glut1 protein levels and glucose uptake.
Cycloheximide sensitivity, the observed kinetics, and both 3 H]2dog-6-P above the control value (ϮSE), where the control value is 136 Ϯ 18 pmol/uterus⅐30 min incubation. The numbers of independent measurements obtained for each time point are 0.25 h (n ϭ 3), 0.5 h (n ϭ 4), 1 h (n ϭ 6), 4 h (n ϭ 4), and 8 h (n ϭ 3). Each measurement represents a pooled sample of two rat uteri.
the increase in the rate of glucose uptake (Fig. 1 ) and the increase in mRNA levels of Glut 1 (Fig. 5) observed after an injection of 1 g E 2 all correlate well with respect to the percent increase, although the initial change in the rate of glucose uptake suggests the existence of a second mechanism. These data strongly suggest that E 2 is up-regulating glucose transport through the increased expression of Glut1. This effect could be the result of E 2 up-regulating transcription of Glut1 mRNA, increasing mRNA half-life, or both types of regulation.
Glucose transporters Glut1 and Glut4 in immature rat uterus do not translocate to the plasma membrane in response to E 2 stimulation
Both Glut1 and Glut4 have been shown to translocate from intracellular vesicles to the cell surface as a means of increasing the rate of glucose transport (20) . This type of upregulation would result in kinetics similar to those observed in E 2 -treated immature rat uteri, an increased V max and a
FIG. 3.
A measurement of Glut2 mRNA levels in the rat uterus. RT-PCR was performed on total RNA isolated from uterus (lane 4). RT-PCR was also performed on total RNA from liver and kidney as positive controls, as they are known to express Glut2 mRNA (lanes 5 and 6). Water controls for both sets of PCR primers were performed (lanes 1 and 2). A control for DNA contamination was performed in the absence of reverse transcriptase enzyme (ϪRT) for all three tissues (lanes 7-9). A positive control for mRNA-specific amplification was performed on the uterine RT reaction with primers to Glut1 and Glut4 mRNAs, which have been shown to be present in the rat uterus (lane 10). No Glut1 or Glut4 target was amplified in uterus without RT (lane 11), indicating that the RT reaction was required. Mol wt standards of the 1-kb ladder (Life Technologies, Inc., Gaithersburg, MD) are shown in lane 3.
FIG. 2.
Glucose transporter protein level in untreated immature rat tissues. Whole protein samples from 19-day-old female Sprague Dawley rats were prepared from brain, kidney, jejunum, skeletal muscle, and uterus. Proteins were separated by SDS-PAGE and transferred to nitrocellulose membrane. Membranes were probed with antibodies to Glut1, Glut2, Glut3, Glut4, or Glut5 (as indicated). Target visualization was performed by horseradish peroxidase-linked chemiluminescence. An arrow indicates the position of the glucose transporter detected by each antibody based on the tissues they are known to be expressed in and their mol wt (brain, Glut1 and Glut3; kidney, Glut5; jejunum, Glut2; skeletal muscle, Glut4).
constant Km. To determine whether the rapid increase in glucose uptake in response to E 2 could be due to translocation of either Glut1 or Glut4 to the plasma membrane, 19-day-old female Sprague Dawley rats were injected with 1 g E 2 2 h before they were killed. Within this time period there was a stimulation of glucose uptake (Fig. 1) , but Glut1 mRNA and proteins levels did not increase (Figs. 4 and 5) . Subcellular fractionations were performed on uterine tissue as described in Materials and Methods. Western blots were performed on equal amounts of proteins from membrane and microsomal fractions of both E 2 -treated and control rats. Blots were probed with antibodies specific for Glut1 and Glut4 to measure translocation to the plasma membrane and, with Na ϩ ,K ϩ -ATPase as a membrane marker, to measure the effectiveness of the fractionation. Na ϩ ,K ϩ -ATPase was detected exclusively in the plasma membrane fractions (Fig. 6 ) and was concentrated relative to whole protein samples (data not shown). There was no significant change in Glut4 distribution between the plasma membrane fraction and the microsomal fraction in control vs. E 2 -stimulated uteri. Glut1 was detected almost exclusively at the plasma membrane in both control and E 2 -stimulated nuclei. Neither glucose transporter translocated to the cell surface in response to E 2 . As a control for the protocol, subcellular fractionation was performed on skeletal muscle that had been treated with insulin, a peptide hormone that is known to cause the translocation of Glut4 (6, 20) . Translocation of Glut4 was observed in response to insulin, indicating the effectiveness of the protocol (Fig. 7) .
Discussion
In this study, the expression of glucose transporters Glut1 through Glut5 was examined in the immature rat uterus. Glut1 and Glut4 were the only two transporters observed, and they were characterized with respect to both protein and mRNA steady state levels over an E 2 treatment time course; the same time course in which the increase in the glucose transport rate was observed. Glut1 protein and mRNA levels were found to increase in immature rat uteri treated with E 2 , but the increase in glucose transport rate started before Glut1 mRNA and protein levels changed. These data are consistent with a type of biphasic response that is common to glucose transport stimulation. To determine whether the translocation of Glut1 and Glut4 to the cell surface could be causing Three uteri were collected for each time point. Total protein was isolated using Tri-Reagent (Molecular Research Center, Inc.). Bradford assays were performed to quantify protein levels, samples were concentrated by trichloroacetic acid precipitation, and equal amounts were analyzed by SDS-PAGE. Separated proteins were transferred to nitrocellulose membrane. The blots were probed with antibodies to Glut1 and Glut4, and visualized with a second degree antibody conjugated to horseradish peroxidase and chemiluminescence. The position of the protein is indicated. Control rats (C) received vehicle. Blots probed with Glut4 were exposed for a significantly longer time than in Fig. 2 to better visualize the low levels of Glut4 in the immature rat uterus. the initial increase in the rate of glucose transport in response to E 2 , Glut1 and Glut4 protein levels were measured in subcellular fractions of immature uteri from rats treated with E 2 . No accumulation of either transporter to plasma-enriched fractions was observed.
Cellular responses to estrogen have been grouped with respect to time as either early (rapid) or late, with early responses occurring only minutes after estrogen treatment. Late responses are assumed to be the result of estrogen altering target gene transcription. However, for the early responses, the mechanisms of action are more difficult to explain because of the time required for transcription to affect a cellular response. The rapid effects of E 2 on immature rat uterine metabolism had been carefully measured by the early 1970s (12) , and one of these effects was a stimulation in the rate of glucose uptake into the immature rat uterus after a single injection of E 2 . This stimulation was observed to begin in less than 1 h after E 2 treatment (7), eventually reaching a plateau of approximately 4-fold greater than the control value, and then diminishing slightly (16) . The stimulation was shown to exhibit kinetics consistent with an increase in transporter number, and the effect was sensitive to cycloheximide, indicating the need for new protein synthesis.
These characteristics, cycloheximide sensitivity and the observed kinetics, agree with the observed increase in Glut1 after E 2 treatment. The increase may be caused by direct estrogen receptor (ER) activation of Glut1 transcription, or it may be a secondary response. The standard mechanism of action through which E 2 can directly alter the transcription of a gene is well characterized. E 2 freely passes through both the plasma and nuclear membranes and binds to the ER protein. ER then mediates the transcription of target genes through nearby sequences collectively referred to as ER elements (EREs). The consensus sequence to which ER binds is the Xenopus laevis vitellogenin A2 gene (21), a palindrome FIG. 6 . A Western blot of microsome and membrane subcellular fractionation from E 2 -treated or control rats to examine translocation of Glut1 and Glut4 proteins in immature rat uteri. Microsomes (left) and membranes (right) were isolated from groups of two rats as described in Materials and Methods. Bradford assays were performed to quantify protein level, and equal amounts were analyzed by SDS-PAGE. Separated proteins were transferred to nitrocellulose membrane; probed with Na ϩ ,K ϩ -ATPase (a membrane marker), Glut1, or Glut4 antibodies (as indicated); and visualized with a secondary, or 2°an-tibody conjugated to horseradish peroxidase and chemiluminescence. Fractions enriched for the membrane marker also appeared to be enriched for the Glut1 and Glut4, and the Western blots using these protein fractions therefore required shorter exposure times than the blots in Fig. 4 . These data were reproducible.
FIG. 7.
A Western blot of microsome and membrane subcellular fractionation from insulin-treated or control rats to examine translocation of Glut4 proteins in skeletal muscle. Plasma membrane and microsome fractions from groups of two rats were isolated as described in Materials and Methods. Bradford assays were performed to quantify protein concentrations, and equal amounts were analyzed by SDS-PAGE. Separated proteins were transferred to nitrocellulose membrane, probed with either Na ϩ ,K ϩ -ATPase (a plasma membrane marker) or Glut4 antibodies (as indicated), and visualized with a second degree antibody conjugated to horseradish peroxidase and chemiluminescence. These data were determined to be reproducible.
with the sequence AGGTCACAGTGACCT. A preliminary examination of 666 bp from the 5Ј-upstream region of rat Glut1 (22) did not reveal this sequence (data not shown), but rat Glut1 still may be transcriptionally regulated directly through ER. Other genes, such as progesterone receptor, are activated by ER through variations in the consensus ERE or through ERE half-sites (23) , and the rat Glut1 5Ј-upstream sequence does contain half-sites (22) .
The increase in Glut1 protein in response to E 2 agrees with the previous cycloheximide and kinetic data, but the timing of the initial increase in the rate of glucose uptake, before Glut1 protein levels change, leaves open the possibility of a second mechanism. Stimulation of Glut1 by peptide hormones, such as insulin, has been shown to occur by at least two mechanisms, an increase in glucose transporter expression through the activation of transcription and/or protein synthesis, and glucose transporter translocation from intracellular vesicles to the plasma membrane. Estrogen has been shown to rapidly activate several components of signal transduction pathways that are also associated with glucose transporter translocation, such as cAMP (24) , the release of intracellular calcium (25) , and mitogen-activated protein kinase (26) . Glut1 and Glut4, the two glucose transporters observed in the immature rat uterus, have both been shown to translocate, and translocation would satisfy the observed kinetics associated with E 2 stimulation. Furthermore, the time required for translocation of glucose transporters fits within the same time window as glucose transport stimulation by E 2 . However, in this defined system, neither Glut1 nor Glut4 increased in plasma membrane fractions 2 h after a single 1-g E 2 injection. It therefore is unlikely that Glut1 or Glut4 translocation has a role in the initial uterine response to E 2 .
Although they are atypical, these data do not represent a unique set of conditions for the stimulation of glucose transport. Inhibitors of oxidative phosphorylation, such as azide, have been characterized in Clone 9 cells (a rat liver cell line that is not transformed and contains only Glut1) as causing a biphasic stimulation of glucose transport (27) . The early phase is a rapid increase in glucose transport of 8-to 12-fold in 2 h and a later phase at 8 -12 h that consists of another 1.6-fold increase above that obtained with the 2-h stimulation. Kinetics associated with the early increase indicate an elevated V max with no change in K m , but no increase in Glut1 protein or mRNA is observed until 8 h after azide treatment. In addition, no increase in Glut1 protein at the plasma membrane is observed (28) , indicating that the increase is not due to the translocation of Glut1. The authors hypothesize that a fraction of the glucose transporter population at the cell surface is inactive and becomes activated in response to azide. In this way both the kinetics and the observed increase in glucose transport can be satisfied. The discussion of these similarities is not intended to suggest that E 2 and azide stimulate glucose transport by the same mechanism. It is important to note that this is not the first description of an early glucose transport response that works predominantly through Glut1, has kinetics indicating an increase in transporter number, results in an eventual up-regulation of Glut1 protein, and cannot be explained by either an increase in Glut1 expression or translocation.
